Recent advancement in the treatment of boys and adolescents with hypogonadism.

Publication Year: 2022

DOI:
10.1177/20420188211065660

PMCID:
PMC8753232

PMID:
35035874

Journal Information

Full Title: Ther Adv Endocrinol Metab

Abbreviation: Ther Adv Endocrinol Metab

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: RAR has received honoraria from CONICET (Argentina) for technology services using the AMH ELISA and royalties derived from an agreement between INSERM (France) and Beckman-Coulter-Immunotech for the development of an AMH ELISA kit, until 2020, as well as lecture honoraria from Novo Nordisk and Sandoz, and travel grants from Biosidus, Merck, Novo Nordisk, Pfizer and Sandoz."

Evidence found in paper:

"Funding: The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially funded by Fondo para la Investigación Científica y Tecnológica (FONCYT, Argentina), grant numbers PIDC 32/2017 and PICT 2972/2018."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025